The DNA replication checkpoint is an inhibitory pathway ensuring that mitosis occurs only after completion of DNA synthesis. Its function may be relevant to the stability of the genome. The essential elements of this checkpoint are ATM/ATR kinases that indirectly lead to the phosphorylation and inhibition of the mitosis-promoting factor (Cdc2/cyclin B1). The function of this checkpoint was analysed in diverse nontransformed and tumour-derived cell lines. All cell lines tested arrested mitosis entry when DNA synthesis was inhibited by hydroxyurea (HU) treatment. But, unlike what has been described in yeast and Xenopus, in normal rat kidney (NRK) cells and NIH 3T3 fibroblasts, the arrest induced by HU treatment was not abrogated by caffeine, an ATM and ATR inhibitor. This indicated the presence of an ATM/ATR-independent response to DNA synthesis inhibition in these nontransformed mammalian cell lines. Interestingly, the behaviour of different tumour cell lines after caffeine treatment varied. While SW480, NP29, NP18 and HeLa cells did not enter mitosis in the presence of caffeine after HU treatment, in CaCo2, DLD1, HCT116 and HT29 caffeine abrogated the checkpoint response. In nontransformed cell lines, lack of cyclin B1 accumulation was observed when DNA synthesis was inhibited. This response was not abrogated by caffeine. In the tumour cell lines, a good correlation between the ability to arrest cell cycle when DNA synthesis was inhibited in the presence of caffeine and the lack of cyclin B1 accumulation was observed. Thus, there is an ATM/ATR-independent checkpoint response that leads to a decrease in cyclin B1 accumulation. However, this response is not functional in some tumour cell lines. Using inhibitors of p38a and b, Mek1, 2 and p53À/À knocked-out fibroblasts, we showed that these proteins were also not involved in this particular checkpoint response. Lack of cyclin B1 accumulation after DNA synthesis inhibition in NRK cells was not due to increased degradation of the protein, but correlated with a decrease in mRNA accumulation.
Introduction
The cell cycle must be tightly regulated to ensure complete and accurate transmission of the genome from parent to daughter cells. To this end, eukaryotic cells employ checkpoints to help ensure the orderly progression and completion of critical events such as DNA replication and chromosome segregation. Some checkpoints identified lead to cell-cycle arrest after DNA damage, inhibition of DNA replication or disruption of the mitotic spindle. As a consequence of checkpoint activation, different transitions of the cell cycle are delayed to allow repair processes or completion of a critical cell-cycle event (Nyberg et al., 2002) . Failure to do this increases genome instability, which is believed to be an essential event in tumour progression (Elledge, 1996; Hartwell, 1999) . Checkpoints contain sensor proteins that monitor the genome, signal transducer proteins and effector proteins that are responsible for arresting the cell cycle and repairing the damage. Most effector proteins are either cell-cycle progression factors or DNA repair machinery (Zhou and Elledge, 2000) .
The DNA replication checkpoint is an inhibitory pathway ensuring that mitosis occurs only after completion of DNA replication (Boddy and Russell, 2001) . It has usually been analysed by hydroxyurea (HU) treatment of the cells, which inhibits ribonucleotide reductase and consequently DNA synthesis. DNA damage induced by UV light or methyl methanesulphonate (MMS) treatment blocks DNA replication fork progression and as a consequence also activates the DNA replication checkpoint (Lupardus et al., 2002; Stokes et al., 2002) . How partially replicated DNA is detected is still unknown, but several observations suggest that the signal arises from the replication machinery itself (D'Urso et al., 1995; Michael et al., 2000; You et al., 2002) . Rad1, Hus1, Rad9, Rad17 and Rad26 genes of yeast are essential for both DNA damage and DNA replication checkpoint (Barlow et al., 1996) . It is thought that these gene products function early in the DNA replication checkpoint response, and probably also act as sensors. Homologues of these Rad genes have been identified in mammalian cells, indicating that cell-cycle checkpoints are conserved through evolution. In Xenopus, binding of Xhus1 to active DNA-polymerase a during normal DNA replication continuously activates the DNA replication checkpoint pathway (You et al., 2002) . Upstream signalling elements of this pathway include the phosphatidylinositol 3-kinase family members, Rad3 in fission yeast, Mec1 in budding yeast and ataxia telangiectasiamutated (ATM) and ATM-related protein (ATR) in metazoans (Kastan and Lim, 2000; Abraham, 2001) . Downstream of these sensor proteins and the ATM and ATR kinases, other protein kinases, Chk1 and Chk2, act to elicit responses to induce cell-cycle arrest. One of these responses is the inhibition of late-origin firing. The second response leads to inactivation of the mitosispromoting factor (Cdc2/cyclin B1), and thus to the prevention of mitosis entry with unreplicated DNA.
The formation and activation of Cdc2/cyclin B1 are highly regulated during the cell cycle. The amount of Cdc2 remains relatively constant, whereas cyclin B1 accumulates during the S and G2 phases. An increase in mRNA levels (Hwang et al., 1995) and a decrease in protein degradation due to the inhibition of the anaphase promoting complex (APC) are responsible for this accumulation (Fang et al., 1998; Zachariae et al., 1998; Lukas et al., 1999) . At the G2 phase, cyclin B1 protein reaches maximal levels and begins to enter the nucleus complexed to Cdc2 in a phosphorylationdependent manner (Hagting et al., 1998 (Hagting et al., , 1999 . Once in the nucleus, the Cdc2/cyclin B1 complex is stabilized by phosphorylation of Cdc2 on Thr161 by Cdkactivating kinase (CAK), and is kept inactive by its immediate phosphorylation on Thr14 and Tyr15 by Wee1 and Myt1 kinases. At mitosis onset, Cdc25 phosphatases dephosphorylate these residues and thereby activate the Cdc2/cyclin B complex (Solomon et al., 1990; Norbury et al., 1991; Krek and Nigg, 1992) . In many systems analysed, inhibition of Cdc2/cyclin B in the presence of unreplicated DNA or UV-damaged DNA occurs owing to the ATR-dependent inactivation of Cdc25 leading to the inhibitory phosphorylation of Cdc2 on its Thr-14 and Tyr-15 residues (Ye and Osmani, 1997; Rhind and Russell, 1998) . In fact, in fission yeast and in Xenopus, Chk1 and Chk2/Cds1 phosphorylate Cdc25 at a 14-3-3 binding site, leading to its cytoplasmic sequestration through the binding of 14-3-3 proteins upon DNA synthesis block (Kumagai and Dunphy, 1999; Lopez-Girona et al., 1999; Yang et al., 1999; Zeng and Piwnica-Worms, 1999) . Although in many organisms, such as yeast and Xenopus and in some mammalian cell lines, caffeine-sensitive kinases (ATM or ATR) (Blasina et al., 1999; Hall-Jackson et al., 1999; Sarkaria et al., 1999) have proved essential to the DNA replication checkpoint, evidence suggests the presence of a caffeine-insensitive response to this checkpoint in human cells. In some human cells, little or no caffeineinduced premature mitosis was observed when DNA replication was blocked. Failure to enter mitosis under these conditions was correlated with low levels of cyclin B1 during S-phase arrest and was overcome when cyclin B1 was transiently overexpressed in these cells (Steinmann et al., 1991; Tam et al., 1995) .
It has been shown that one of the DNA replication checkpoint functions is to suppress gross chromosome rearrangements that result from the aberrant repair of DNA damage that normally occurs during DNA replication or from misfiring of origins of replication (Myung et al., 2001) . As chromosome instability could help cancer development, we attempted to analyse the ability of nontransformed cell lines and diverse tumour cells to arrest cell-cycle progression in response to DNA synthesis inhibition. Our results indicate the existence of a caffeine-insensitive response to the DNA replication checkpoint in nontransformed mammal cell lines, which acts as a complementary mechanism to the ATM/ATRdependent response to ensure that mitosis does not take place before completion of DNA replication. This response, which includes the inhibition of cyclin B1 expression, is not functional in some cancer-cell lines. To allow re-entry to the cell cycle, quiescent cells were trypsinized and subcultured at a lower density in a fresh growing medium.
Materials and Methods

Cell
Gel electrophoresis and immunoblotting
Cells were lysed in a buffer containing 2% SDS, 67 mM TrisHCl pH 6.8 and 10 mM EDTA, and sonicated twice for 10 s. Protein content was measured by the Lowry procedure, using bovine serum albumin (BSA) as standard. These cell extracts were electrophoresed in SDS-polyacrylamide gels, essentially as described (Laemmli, 1970) . After electrophoresis, the proteins were transferred to Immobilon-P (Millipore) strips for 2 h at 60 V. The sheets were preincubated in TBS (20 mM Tris-HCl pH 7.5, 150 mM NaCl), 0.05% Tween 20 and 5% defatted powdered milk for 1 h at room temperature and then incubated for 1 h at room temperature in TBS, 0.05% Tween 20, 1% BSA and 0.5% defatted milk powder containing the appropriate antibodies cyclin B1 (Upstate, cat. # 05-158, 1 : 200 dilution), cdk4 (Santa Cruz, sc-260, 1 : 200 dilution) or phospho-p38 (Cell Signaling Technology, cat. # 9211, 1 : 1000 dilution). After washing in TBS, 0.05% Tween 20 (three times, 10 min each), the sheets were incubated with a peroxidasecoupled secondary antibody (Bio-Rad, 1 : 2000 dilution) for 1 h at room temperature. After incubation, the sheets were washed three times in TBS, 0.05% Tween 20 and twice in TBS. The reaction was viewed by ECL (Amersham). Images were then scanned and intensities were quantified using Quantity One software (BioRad).
Immunoprecipitation and Cdc2 kinase assay
Cells were lysed for 30 min at 41C in IP buffer (50 mM Tris-HCl pH 7.4, 0.1% Triton X-100, 5 mM EDTA, 250 mM NaCl, 1 mM NaF, 0.1 mM Na 3 VO 4 , 1 mM phenyl-methyl-sulphonyl fluoride, 1 mg/ml aprotinin and 10 mg/ml leupeptin). Lysates were clarified by centrifuging at 10 000 g for 10 min. The supernatant fraction protein content was measured using the Bradford method, and 500 mg of protein from the lysates were incubated with 2 mg of anticyclin B1 (Upstate, cat. # 05-158) antibodies or with 2 mg of mouse IgGs overnight at 41C. Protein immunocomplexes were then incubated with 20 ml protein G-Sepharose (Sigma) for 1 h at 41C, collected by centrifuging and washed three times in IP buffer and once in kinase buffer (50 mM HEPES-Na pH 7.4, 10 mM magnesium acetate and 10 mM DTT) and then incubated in kinase buffer containing 1 mCi [g-32 P]ATP (Amersham) and 3 mg histone H1 for 30 min at 301C in a final volume of 30 ml. The samples were then boiled for 4 min and electrophoresed on SDS-polyacrylamide gels. The gels were then stained with Coomassie blue, dried and exposed to an imaging plate (Fuji). Data were recorded using Personal FX (Bio Rad) and analysed with Quantity One software (Bio Rad).
P38 kinase activity assay
To determine p38 activity, activation of the kinase MAP-KAPK2, a substrate of p38, was evaluated. Cells were lysed for 30 min at 41C in lysis buffer containing 25 mM HEPES pH 7.5, 0.1% Triton X-100, 300 mM NaCl, 1.5 mM MgCl 2 , 0.2 mM EDTA, 0.5 mM DTT, 1 mM NaF, 1 mM PMSF, 0.1 mM Na 3 VO 4 , 1 mg/ml aprotinin and 10 mg/ml leupeptin. Lysates were clarified by centrifugation and aliquots containing 500 mg of protein were incubated with 2 mg of anti-MAPKAPK2 (Santa Cruz Biotech., cat. # sc-6221) antibodies or with 2 mg of goat IgGs for 2.5 h at 41C. Protein immunocomplexes were then incubated with 20 ml protein G-Sepharose for 1 h at 41C, collected by centrifuging and washed twice with lysis buffer and twice with kinase assay buffer (25 mM HEPES pH 7.5, 25 mM MgCl 2 , 2 mM DTT, 100 mM Na 3 VO 4 , 1 mM NaF), and then incubated in kinase buffer containing 1 mCi [g-32 P]ATP and 2 mg Hsp27 (Stressgen) in a final volume of 30 ml for 30 min at 301C. A measure of 10 ml of Laemmli's sample buffer was added and the samples were boiled for 4 min and electrophoresed. The gel was stained with Coomassie blue, dried and exposed to an imaging plate.
Laser scanning cytometry (LSC) analysis
Cells were fixed with ethanol : acetic acid (95 : 5) for 5 min at room temperature. Mitotic cells were detected with antiphospho-histone H3 antibody (Upstate, 1 : 200 dilution) and then with a secondary FITC-conjugated antibody (1 : 100 dilution). The total number of cells was quantified by DNA staining with propidium iodide (50 mg/ml) after RNase A (200 mg/ml) treatment. A minimum of 10 000 events were recorded for each sample. An Argon laser set at 5 mW was used to excite the phluorochromes, and the filters used were 530/30 nm for FITC and 625/28 nm for propidium iodide. Cell DNA content was monitored by propidium iodide staining, as described above.
Measurement of cyclin B1 mRNA levels
Total cell RNA was extracted from synchronized NRK and HCT116 cells using the RNAqueous kit (Ambion). Samples were run in an agarose gel containing formaldehyde and transferred onto a Hybond N þ (Amersham) nylon membrane. The membrane was hybridized with a 32 P-labelled human cyclin B1 cDNA probe obtained by KpnI and EcoRI digestion of a vector containing the full-length human cyclin B1 cDNA, and exposed to an imaging plate (Fuji). Data were obtained with Personal FX (Bio Rad) and analysed with Quantity One (Bio Rad).
Results
Caffeine does not abrogate HU-induced checkpoint in nontransformed cell lines, but it does in some tumour-derived cells
The capacity of diverse nontransformed and tumourderived cell lines to arrest cell-cycle progression in response to DNA synthesis inhibition and the dependence of this response on ATM/ATR action were analysed. NRK and NIH3T3 were used as nontransformed cell lines. Diverse colorectal (HCT116, CaCo2, DLD1, HT29 and SW480), pancreatic (NP18 and NP29) and cervix (HeLa) tumour-derived cell lines were used as tumour cells. Asynchronously, cycling cells were treated with HU to block DNA synthesis. The percentage of cells that could enter mitosis in the presence of HU was analysed during a period of time from 24 to 36 h after HU addition by counting phospho-H3 positive cells. H3 phosphorylation is a good marker of mitosis entry because it is one of the earliest events in mitosis and is not directly linked to DNA synthesis. Obviously, mitosis entry could not be determined by the quantification of DNA content in the cells because, as we were inhibiting DNA synthesis, the DNA content would always be the same as at the moment of HU addition. As shown in Table 1 and Figure 1 , none of the cell lines entered mitosis in the presence of HU. This indicated that in all cells, nontransformed or tumour cells, a checkpoint response was activated that inhibited mitosis entry when DNA synthesis was blocked. In order to check the presence of an ATM/ATR-independent response in the different cell lines, DNA synthesis was blocked with HU as indicated above, but 24-25 h after HU 5 mM caffeine was added in order to inhibit ATM and ATR. As shown in Table 1 and Figure 1 , even upon addition of caffeine, HU-treated NRK or NIH3T3 cells showed low levels of H3 phosphorylation, indicating that mitosis entry was still inhibited. The behaviour of the tumour cell lines varied. In NP29, NP18, HeLa and SW480 cells, as in NRK cells, phospho-H3 positive in HU-treated cells was low even when caffeine was added. However, caffeine completely abrogated the checkpoint response of HCT116, CaCo2, HT29 and DLD1 tumour cell lines. As shown in Figure 1 , after caffeine addition these cells re-entered mitosis. These experiments showed the presence of an ATM/ATRindependent response to HU treatment in nontransformed cell lines, which was nonfunctional in some cancer cell lines.
To avoid long exposure of the cells to HU and to caffeine, the experiments were repeated using synchronized cell lines. NRK, HCT116 and NP18 cells were synchronized by serum starvation and then activated to proliferate. DNA synthesis was blocked when cells were in the S phase by HU addition in the presence or absence of caffeine. A few hours later, when under normal conditions cells were expected to be in mitosis, the percentage of mitotic cells counted was determined by counting phospho-H3 positive cells. Consistent with the results shown above, none of the cell lines entered mitosis when DNA synthesis was inhibited, but inhibition of ATM and ATR by caffeine allowed HCT116 cells to enter mitosis (H3 phosphorylation) even with unreplicated DNA, while NRK and NP18 cells were still arrested (Figure 2 ).
Cdc2 activity decrease observed in S-phase arrested cells is partially reverted by caffeine in HCT116 cells, but not in NRK cells
The main target of the checkpoint machinery to inhibit mitosis entry is Cdc2/cyclin B. We tested whether HU treatment inhibited Cdc2/cyclin B1 activity and if this inhibition was abrogated by caffeine treatment. We chose a cell line that did not enter mitosis in the presence of caffeine, NRK, and a cell line that did, HCT116, when DNA synthesis was inhibited. As shown in Figure 3 , Cdc2/cyclin B1 activity decreased in both cell lines upon 24 h of HU treatment, but while the addition of caffeine for 8 or 12 h restored Cdc2/cylin B1 activity in HCT116 it did not in NRK cells. Thus there was an ATM/ATR-independent inhibition of Cdc2/cyclin B1 activity in NRK cells upon DNA synthesis inhibition, but not in HCT116 cells.
Effect of S-phase arrest on cyclin B1 accumulation
Cdc2/cyclin B1 activity is mostly downregulated by inhibition of its dephosphorylation by Cdc25, response that is ATM/ATR-dependent. To find another regulatory mechanism of Cdc2 induced by the DNA replication checkpoint, we analysed the accumulation of cyclin B1 in different cell lines along the S and G2 phases of the cell cycle under control conditions or upon inhibition of DNA synthesis. In NRK cells synchronously activated to proliferate from quiescence, cyclin B1 accumulated between 18 and 24 h (Figure 4, nontreated lanes) . Later, cells exited mitosis and cyclin B1 decreased (data not shown). To investigate whether DNA synthesis arrest induced an inhibition of cyclin B1 accumulation, HU or aphidicolin was added to the cells during the S phase (18 h after activation). Cells were lysed 2, 4 or 6 h later (20, 22 and 24 h after proliferative activation) and cyclin B1 levels were analysed by Western blotting. As shown in Figure 4 , treatment with either HU or aphidicolin inhibited cyclin B1 accumulation observed in the absence of any treatment between 18 and 24 h after proliferative activation of the cells. The same results of cyclin B1 accumulation inhibition after HU treatment were observed with other nontransformed cell lines, such as NIH3T3, and with MEFs ( Figure 4) . Differences in the relative increase of cyclin B1 between cell lines is partially due to the fact that the percentage of cells in the S phase when HU was added changed from one cell line to another as shown by the LSC data (Figure 4c ). These results indicated that, in response to DNA synthesis inhibition, nontransformed cells activated a checkpoint that inhibited not only G2-M transition, as previously shown, but also one of the intra-S-phase events, that is, accumulation of cyclin B1.
The capacity of the diverse tumour cell lines to inhibit cyclin B1 accumulation in response to DNA synthesis inhibition was analysed. HCT116, SW480, NP18, NP29, HT29 and CaCo2 cells were serum-starved and then activated to proliferate. Once cells were in the S phase, HU was added to the media and then the cells were collected at different times. Interestingly, the response to DNA synthesis inhibition of the different tumour cell lines was diverse. NP29 and NP18 cells (like NRK, NIH3T3 or MEF cells) did not accumulate cyclin B1 when treated with HU. In HCT116 and CaCo2, HU did not have any effect on cyclin B1 accumulation and HT29 and SW480 showed partial increase of cyclin B1 when HU treated. Thus, an alteration of this particular checkpoint response was observed in some of the tumour cell lines analysed ( Figure 5 ).
Decrease of cyclin B1 upon HU-induced arrest is p53-and ATM/ATR-independent
Since a good correlation was observed between the decrease in cyclin B1 upon HU treatment and the insensitivity to caffeine, we analysed whether the decrease in cyclin B1 was also independent of the ATM/ ATR pathway. We also wanted to study the involvement of p53, a key element in the ATM/ATRdependent response to DNA damage and replication arrest. To this end, S-phase-synchronized NRK cells and p53À/À MEFs were treated with HU in the presence of 5 mM caffeine. Cells were lysed 4 h later and the amount of cyclin B1 was analysed by Western blotting. Cyclin B1 levels decreased after HU treatment regardless of the addition of caffeine in both NRK and p53À/À MEFs ( Figure 6 ). In conclusion, neither ATR, ATM nor p53 were involved in the signalling pathway Figure 2 Effect of caffeine on mitosis entry inhibition induced by HU treatment during the S phase. NRK, NP18, and HCT116 cells were made quiescent by serum starvation and then activated to proliferate, as indicated in Materials and methods. All the times indicated in the figure indicated time after proliferative activation. Once cells were in the S phase (13, 18 or 16 h for HCT116, NP18 or NRK cells respectively), as indicated by the DNA content, they were treated with 1.5 mM HU or with 1.5 mM HU þ 5 mM caffeine (Caf) until the time of collection indicated in the figure. DNA content and the percentage of P-H3 positive cells were determined as indicated in Materials and methods Figure 3 Effect of caffeine on Cdc2/cyclin B1 activity in HU-treated S-phase cells. Asynchronously growing NRK and HCT116 cells were treated with 1.5 mM HU for 24 h and then when indicated, 5 mM caffeine was added to the media. Cells were collected at the times indicated and Cdc2/cyclin B1 activity was determined, as indicated in Materials and methods Replication checkpoint and cyclin B1 levels R Florensa et al leading to the inhibition of cyclin B1 expression on DNA synthesis inhibition.
Decrease of cyclin B1 on HU-induced arrest is p38a,b and ERK1,2-independent
It has been shown that one of the kinases of the MAPK family, p38, contributes to cell-cycle arrest in response to DNA damage (Bulavin et al., 2001) . Its possible participation in the inhibition of cyclin B1 accumulation upon DNA blockade was investigated. S-phase-synchronized NRK cells were treated for 4 h with HU in the presence of SB203580 (p38a and b inhibitor). As shown in Figure 7 , although HU-treated cells show higher p38 phosphorylation than nontreated cells, the inhibition of p38a and b did not disrupt the checkpoint response that led to cyclin B1 expression regulation. In order to confirm the inhibitory activity of SB203580 on p38 under our experimental conditions, the activation of a kinase substrate of p38 was analysed (Figure 7c ). The same results were observed with the p38 inhibitor SB202190 (data not shown). Although not previously shown to participate in DNA damage or DNA synthesis arrest checkpoint response, we also wanted to test the participation of another member of the MAPK family, Erk1,2. As shown also in Figure 7 , inhibition of these kinases by UO126 did not have any effect on cyclin B1 levels. The inhibitory activity of UO126 was confirmed 
DNA synthesis inhibition does not enhance cyclin B1 degradation
The regulation of cyclin B1 degradation is one of the most important mechanisms for controlling cyclin B1 levels during the cell cycle. Its proteolysis is ubiquitinand proteasome-dependent. We tested whether the downregulation of cyclin B1 observed in NRK cells after DNA replication inhibition was due to greater degradation. S-phase-synchronized cells were treated with HU and, at the same time, the proteasome inhibitor lactacystin was added to the media. Although an increase in cyclin B1 could be seen in some experiments in both HU-treated and nontreated cells, cyclin B1 levels in HU-treated cells in any case did not reach the levels of nonarrested cells (Figure 8 ). Nor did the inhibitor of proteasome MG132 recover the levels of cyclin B1 in p53À/À cells (Figure 8) . Furthermore, the half-life of cyclin B1 was evaluated in S-phase NRK cells in the presence or absence of HU. NRK cells were activated to proliferate from quiescence and once in S-phase (18 h) protein synthesis was inhibited by cycloheximide addition in the presence or absence of HU and cyclin B1 levels analysed by Western blotting. In both cases, the half-life of the protein was 110 min, confirming that the lack of cyclin B1 accumulation in HU-treated cells was not due to an increased degradation of the protein.
DNA synthesis arrest inhibits cyclin B1 mRNA accumulation
Since no effect on cyclin B1 stability was observed upon HU addition to S-phase cells, northern blots were performed to analyse whether the decrease in cyclin B1 protein levels correlated with a decrease in the mRNA levels. S-phase-synchronized NRK cells were treated for 2 h with HU to arrest DNA synthesis, or allowed to continue the cell cycle (control nontreated cells). As shown in Figure 9 , cyclin B1 mRNA increased as cells progressed from the S phase to G2/M, but no increase was observed in HU-treated cells. Thus, lack of cyclin B1 accumulation in NRK cells upon DNA synthesis blockage correlated with the decrease in cyclin B1 protein levels. 
Discussion
The capacity of nontransformed and diverse tumour cells to arrest cell-cycle progression in response to DNA synthesis inhibition was analysed here. Our data show that, in nontransformed rat and mouse cell lines and in some tumour human cell lines, there is an ATM-and ATR-independent response to DNA synthesis arrest that leads to Cdc2 downregulation and, consequently, to inhibition of mitosis entry. Interestingly, this checkpoint response is disrupted in some of the human tumourderived cell lines analysed. We also presented evidence indicating that this checkpoint response includes a decrease in cyclin B1 protein accumulation, which is not found in the tumour cells that failed to arrest when ATM and ATR were inhibited. Several mechanisms participate in the inhibition of Cdc2/cyclin B1 activation on DNA synthesis blockade by HU treatment. In Xenopus and yeast, cytoplasmic retention of Cdc25 and, consequently, the inhibition of nuclear Cdc2 activation seems to be the most relevant mechanism (Kumagai and Dunphy, 1999; Lopez-Girona et al., 1999; Yang et al., 1999; Zeng and PiwnicaWorms, 1999) . Additional mechanisms to inhibit Cdc2/ cyclin B1 after DNA damage, which could also act in response to DNA synthesis inhibition, have been described: retention of the complex in the cytoplasm (Chan et al., 1999) , p53-dependent expression and binding of Gadd45 and p21 to Cdc2/cyclin B1 complex (Zhan et al., 1999; Taylor and Stark, 2001) , degradation of Cdc25C (Chen et al., 2002) and inhibition of wee1 degradation (Michael and Newport, 1998) . Most of these mechanisms have been shown to rely on ATM or ATR activation.
While reviewing our work, a paper came out showing that checkpoint delay in response to stalled DNA replication is intact in ATR/ATM double-knockout cells (Brown and Baltimore, 2003) . In agreement with these data and confirming previous data from Steinmann et al. (1991) , our results show that there is a caffeine-insensitive response to DNA synthesis arrest at least in mouse, rat and human cells. Therefore, a response different from those indicated above to induce arrest upon HU treatment in the presence of caffeine should exist. We show that this caffeine-insensitive response includes the inhibition of cyclin B1 accumulation that should be observed in normal progression of the S phase and G2 phase. Low levels of cyclin B1 could be sufficient to keep Cdc2/cyclin B1 kinase activity low, thus maintaining checkpoint functionality when the ATM/ATR pathway is inhibited. Lack of cyclin B1 protein accumulation in human cell lines treated for 16 h with HU, contrasting with hamster cell lines, was also published (Steinmann et al., 1991) , but in these experiments, lower cyclin B1 levels could only represent more cells arrested in G1/S in one cell type than in the other. We show here, using synchronized cells, that accumulation of cyclin B1 occurring under normal conditions during the S phase is inhibited when cells are treated with HU. We also show that this effect is not abrogated by caffeine and so is ATM-and ATRindependent. It has previously been shown that during the S phase, APC is inhibited in a Cdk2-dependent manner and, consequently, cyclin B1, which is targeted to degradation by APC-dependent ubiquitination from anaphase to the end G1, is stabilized (Lukas et al., 1999) . We treated S-phase-arrested cells with proteasome inhibitors. Although an increase of cyclin B1 was observed, this increase was the same in the presence as in the absence of HU, indicating that lack of cyclin B1 accumulation in HU-treated cells was not due to increased degradation. However, S-phase cells treated with HU had lower levels of cyclin B1 mRNA than Sphase cells not treated with HU. Therefore, lack of cyclin B1 is mainly due to a decrease in mRNA accumulation after DNA synthesis inhibition and not to increased degradation of the protein. Transcriptional regulation of cyclin B1 gene (Hwang et al., 1995 (Hwang et al., , 1998 Crawford and Piwnica-Worms, 2001 ) as well as regulation of cyclin B1 mRNA stability (Wang et al., 2002) during the cell cycle have been reported. Furthermore, it has been shown that induction of G2 arrest by doxorubicin-mediated DNA damage in C2C12 nontransformed skeletal muscle cells leads to the inhibition of cyclin B1 transcription. Unlike in our results, this response was p53-mediated Taylor et al., 1999; Manni et al., 2001) . In g-irradiated G2/M arrested HeLa cells, the half-life of cyclin B1 mRNA was also reduced . But, to our knowledge, no studies on cyclin B1 mRNA transcription or stability when DNA synthesis is inhibited have been reported.
Looking for transduction pathways involved in signalling from DNA synthesis arrest to downregulation of cyclin B1, which could be altered in the tumour cell lines, we tested the dependence on p53 and p38 kinase. Cyclin B1 mRNA levels after HU treatment of S-phase NRK cells. S-phase-synchronized NRK cells were nontreated or treated with HU. At the times indicated after proliferative activation, cells were lysed, RNA purified and the levels of cyclin B1 mRNA determined by northern blot. EtBr staining of the gel is shown as a loading control. Quantification of cyclin B1 mRNA levels corrected by EtBr staining is also shown P53 is a major protein involved in DNA damage signalling (Hirao et al., 2000) . Consistent with the fact that p53 is a downstream element of the ATM and ATR signalling pathways (Abraham, 2001) , the decrease in cyclin B1 levels observed on DNA synthesis inhibition was also observed in p53À/À MEFs and in SW480 cells (with mutated p53). Our results also corroborate recent findings, indicating a p53-independent decrease in cyclin B1 mRNA levels in HeLa cells upon UV light irradiation (Crawford and Piwnica-Worms, 2001) . A role for p38a,b kinase in regulating Cdc25B phosphorylation and hence G2/M transition after UV light irradiation has been proposed (Bulavin et al., 2001 (Bulavin et al., , 2002 , and most recently it has been shown that enforced activation of MEKK3 in Rat1 cells induced p38a/b2-dependent cycle arrest at G2. But, our results, using p38a and b inhibitors, indicate that downregulation of cyclin B1 upon HU treatment is p38a-and b-independent. But still it is possible that the observed effects are dependent on another p38 isoform, as for instance p38g.
One could argue that lack of cyclin B1 mRNA and protein accumulation could be just a direct consequence of the DNA synthesis blockade and not a checkpoint response. But the fact that in some organisms, such as yeast (Lopez-Girona et al., 1999; Zeng and Piwnica-Worms, 1999) , Xenopus (Kumagai and Dunphy, 1999; Yang et al., 1999) or, as we show here in some tumour cell lines, cyclin B1 accumulation is observed when DNA synthesis is inhibited indicates that its accumulation is not directly linked to DNA synthesis. Therefore, an additional mechanism, a checkpoint, must exist that blocks cyclin B1 accumulation when DNA synthesis is inhibited. This mechanism, although not present in lower organisms such as yeast or Xenopus, is present in nontransformed rat and mouse cell lines and in some human cell lines. This ATM/ATR-independent checkpoint response may have appeared late in evolution as a complementary mechanism to avoid mitosis entry before completion of DNA replication.
Here, we show that in some cancer cells, this response is nonfunctional. Cell lines that did not accumulate cyclin B1 in the presence of HU did not enter mitosis in the presence of caffeine and thus have a complete functional checkpoint, while cells that accumulate cyclin B1 even in the presence of HU, enter mitosis when DNA synthesis is inhibited in the presence of caffeine. As all the cell lines tested are still able to arrest the cell cycle through the ATM/ATR-dependent response, one could argue that this alteration may not be relevant for these cells. However, under certain circumstances, such as DNA damage that also activates an ATM/ATRdependent checkpoint response, this pathway may become saturated and, in consequence, unable to arrest the cell cycle. In this case, the ATM/ATR-independent response could be essential to inhibit mitosis entry with nonfully replicated DNA. As a result, lack of this checkpoint response in some tumour cells could lead in some circumstances to an increase in genomic instability and consequently contribute to the transformation process.
It is possible that, parallel to inhibition of Cdc2/cyclin B1 activation, this caffeine-insensitive checkpoint response also restrains firing of late origins. Although in all the cell types analysed up to now the checkpoint responses that lead to an intra-S-phase arrest have proved ATR-or Mec1-dependent (Santocanale and Diffley, 1998; Dimitrova and Gilbert, 2000; HekmatNejad et al., 2000; Feijoo et al., 2001) , it would be interesting to know whether an ATR-independent response mutated in some cancer cells exists in mammals. This is also relevant to oncogenesis, as uncontrolled firing of origins also induces greater genomic instability (Tanaka and Diffley, 2002) .
